US Shop

New user? / Forgot your password?

0 Item | 0,00 €

Filter

Benzo[k]fluoranthene Solution (Solvent: Cyclohexane)

Item number689865
CAS207-08-9
FormulaC20H12
Molecular weight252,31 g/mol
Quantity 1X5ML
Concentration100 µg/ml
SolventCyclohexane
storage conditions4 °C
CoA / MSDSRetrieve CoA
Retrieve MSDS
Benzo[k]fluoranthene

Price

Please log in.

Part of Product groups:
Product Variations:

Product

Catalog No./ CAS No.

Quantity

Price

Benzo[k]fluoranthene solution
Concentration: 10.0 µg/ml
Solvent: Acetonitrile

Benzo[k]fluoranthene solution

681669
207-08-9

1X10ML

Please log in.

Benzo[k]fluoranthene solution
Concentration: 100 µg/ml
Solvent: Cyclohexane

Benzo[k]fluoranthene solution

689865
207-08-9

1X5ML

Please log in.

Safety Data Sheetaccording to Regulation (EC) No 1907/2006 (REACH)
Classifications according to Regulation (EC) No 1272/2008.
Printdate 25.12.2024
IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING
Product name:Benzo[k]fluoranthene
Catalog No.:689865
Relevant identified uses of the substance or mixtureIdentified: Laboratory chemical
uses: R&D
Uses advised against:HPC Standards GmbH
Am Wieseneck 7

04451 Cunnersdorf
Deutschland


Tel. +49 34291 3372-36
Fax. +49 34291 3372-39
contact@hpc-standards.com
Emergency telephone numberHPC Standards Tel. +49 34291 3372-36
This number is only available during office hours.
HAZARDS IDENTIFICATION2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008
Flammable liquids (Category 2), H225
Skin irritation (Category 2), H315
Specific target organ toxicity - single exposure (Category 3), Central nervous system, H336
Aspiration hazard (Category 1), H304
Acute aquatic toxicity (Category 1), H400
Chronic aquatic toxicity (Category 1), H410
Label elements
Pictogramflamme
flamme
GHS07 exclam
exclam
GHS08 silhouete
silhouete
GHS09 Aquatic-pollut-red
Aquatic-pollut-red
Signal word Danger
Hazard statement(s)
H225 Highly flammable liquid and vapour.
H304 May be fatal if swallowed and enters airways.
H315 Causes skin irritation.
H336 May cause drowsiness or dizziness.
H410 Very toxic to aquatic life with long lasting effects.
Precautionary statement(s)
P210 Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P261 Avoid breathing vapours.
P273 Avoid release to the environment.
P301 + P310 IF SWALLOWED: Immediately call a POISON CENTER or doctor/
physician.
P331 Do NOT induce vomiting.
P501 Dispose of contents/ container to an approved waste disposal plant.
Supplemental Hazard
Statements
none
2.3 Other hazards - none
COMPOSITION/INFORMATION ON INGREDIENTS3.1 Substances
Formula : C6H12
Molecular Weight : 84,16 g/mol
CAS-No. : 110-82-7
EC-No. : 203-806-2
Index-No. : 601-017-00-1
Registration number : 01-2119463273-41-XXXX
Hazardous ingredients according to Regulation (EC) No 1272/2008
Component Classification Concentration
Cyclohexane
CAS-No.
EC-No.
Index-No.
110-82-7
203-806-2
601-017-00-1
Flam. Liq. 2; Skin Irrit. 2;
STOT SE 3; Asp. Tox. 1;
Aquatic Acute 1; Aquatic
Chronic 1; H225, H304, H315,
H336, H410
<= 100 %
Hazardous ingredients according to Directive 1999/45/EC
Component Classification Concentration
Cyclohexane
CAS-No.
EC-No.
Index-No.
110-82-7
203-806-2
601-017-00-1
F, Xn, N, R11 - R20 - R38 -
R65 - R67 - R50/53
<= 100 %
FormulaC20H12
Molecular Weight (g/mol)252.31
CAS-No.207-08-9
FIRST AID MEASURES4.1 Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
If swallowed
Do NOT induce vomiting. Never give anything by mouth to an unconscious person. Rinse mouth with
water. Consult a physician.
4.2 Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in
section 11
4.3 Indication of any immediate medical attention and special treatment needed
no data available
FIRE-FIGHTING MEASURES5.1 Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
5.2 Special hazards arising from the substance or mixture
Carbon oxides
5.3 Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
5.4 Further information
Use water spray to cool unopened containers.
ACCIDENTAL RELEASE MEASURES6.1 Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid breathing vapors, mist or gas. Ensure adequate ventilation.
Remove all sources of ignition. Evacuate personnel to safe areas. Beware of vapours accumulating to
form explosive concentrations. Vapours can accumulate in low areas.
6.2 Environmental precautions
Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the
environment must be avoided.
6.3 Methods and materials for containment and cleaning up
Contain spillage, and then collect with an electrically protected vacuum cleaner or by wet-brushing and
place in container for disposal according to local regulations (see section 13).
6.4 Reference to other sections
For disposal see section 13.
HANDLING AND STORAGE7.1 Precautions for safe handling
Avoid contact with skin and eyes. Avoid inhalation of vapour or mist.
Keep away from sources of ignition - No smoking.Take measures to prevent the build up of electrostatic
charge.
7.2 Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Containers which are
opened must be carefully resealed and kept upright to prevent leakage.
Store under inert gas.
7.3 Specific end uses
no data available
EXPOSURE CONTROLS/PERSONAL PROTECTION8.1 Control parameters
Components with workplace control parameters
8.2 Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and
at the end of workday.
Personal protective equipment
Eye/face protection
Face shield and safety glasses Use equipment for eye protection tested and approved under
appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
Complete suit protecting against chemicals, Flame retardant antistatic protective clothing, The type
of protective equipment must be selected according to the concentration and amount of the
dangerous substance at the specific workplace.
Respiratory protection
Where risk assessment shows air-purifying respirators are appropriate use a full-face respirator
with multi-purpose combination (US) or type ABEK (EN 14387) respirator cartridges as a backup
to engineering controls. If the respirator is the sole means of protection, use a full-face supplied air
respirator. Use respirators and components tested and approved under appropriate government
standards such as NIOSH (US) or CEN (EU).
PHYSICAL AND CHEMICAL PROPERTIES9.1 Information on basic physical and chemical properties
a) Appearance Form: liquid
Colour: colourless
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing
point
Melting point/range: 4 - 7 °C - lit.
f) Initial boiling point and
boiling range
80,7 °C - lit.
g) Flash point -18,0 °C - closed cup
h) Evapouration rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower
flammability or
explosive limits
Upper explosion limit: 9 %(V)
Lower explosion limit: 1 %(V)
k) Vapour pressure 225,0 hPa at 37,7 °C
102,7 hPa at 20,0 °C
l) Vapour density no data available
m) Relative density 0,779 g/cm3 at 25 °C
n) Water solubility no data available
o) Partition coefficient: noctanol/
water
log Pow: 3,44
p) Auto-ignition
temperature
260,0 °C
q) Decomposition
temperature
no data available
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
9.2 Other safety information
no data available
STABILITY AND REACTIVITY10.1 Reactivity
no data available
10.2 Chemical stability
Stable under recommended storage conditions.
10.3 Possibility of hazardous reactions
no data available
10.4 Conditions to avoid
Heat, flames and sparks. Extremes of temperature and direct sunlight.
10.5 Incompatible materials
Strong oxidizing agents
10.6 Hazardous decomposition products
Other decomposition products - no data available
In the event of fire: see section 5
TOXICOLOGICAL INFORMATION11.1 Information on toxicological effects
Acute toxicity
LD50 Oral - rat - 12.705 mg/kg
LC50 Inhalation - rat - 4 h - 34.000 mg/l
(OECD Test Guideline 403)
LD50 Dermal - rabbit - > 2.000 mg/kg
Skin corrosion/irritation
Skin - rabbit
Result: No skin irritation
Remarks: Classified according to Regulation (EU) 1272/2008, Annex VI (Table 3.1/3.2)
Serious eye damage/eye irritation
Eyes - rabbit
Result: Mild eye irritation
Respiratory or skin sensitisation
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
May cause drowsiness or dizziness.
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
May be fatal if swallowed and enters airways.
Additional Information
RTECS: GU6300000
Central nervous system depression, Drowsiness, Irritability, Dizziness, Gastrointestinal disturbance, Lung
irritation, chest pain, pulmonary edema
ECOLOGICAL INFORMATION12.1 Toxicity
no data available
12.2 Persistence and degradability
no data available
12.3 Bioaccumulative potential
no data available
12.4 Mobility in soil
no data available
12.5 Results of PBT and vPvB assessment
PBT/vPvB assessment not available as chemical safety assessment not required/not conducted
12.6 Other adverse effects
Very toxic to aquatic life with long lasting effects.
DISPOSAL CONSIDERATIONS13.1 Waste treatment methods
Product
Burn in a chemical incinerator equipped with an afterburner and scrubber but exert extra care in igniting
as this material is highly flammable. Offer surplus and non-recyclable solutions to a licensed disposal
company.
Contaminated packaging
Dispose of as unused product.
TRANSPORT INFORMATION14.1 UN number
ADR/RID: 1145 IMDG: 1145 IATA: 1145
14.2 UN proper shipping name
ADR/RID: CYCLOHEXANE, SOLUTION
IMDG: CYCLOHEXANE, SOLUTION
IATA: Cyclohexane, SOLUTION
14.3 Transport hazard class(es)
ADR/RID: 3 IMDG: 3 IATA: 3
14.4 Packaging group
ADR/RID: II IMDG: II IATA: II
14.5 Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
14.6 Special precautions for user
no data available
REGULATORY INFORMATIONThis safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
15.1 Safety, health and environmental regulations/legislation specific for the substance or mixture
no data available
15.2 Chemical Safety Assessment
For this product a chemical safety assessment was not carried out
OTHER INFORMATIONThe above information is believed to be correct but does not purport to be all inclusive and shall be used only as a guide. The information in this document is based on the present state of our knowledge and is applicable to the product with regard to appropriate safety precautions. It does not represent any
guarantee of the properties of the product. For lab use only!